Abstract
The POCT belongs to the segmentation of the IVD industry and is one of the fastest-growing segments of the IVD industry in recent years. With the continuous advancement of biotechnology, there are two trends in medical devices: one is much more “high, precise, integrated,” the other is “simple, convenient, personal health management.” The POCT products that are compact in size, simple in operation, and timely in results are produced under such a background and have been rapidly developed. POCT is characterized by rapid (time of output), convenience (no or very little sample pre-processing, simple operation), and the diagnosis time is extremely critical when acute diseases such as myocardial infarction occur; in epidemics breaking, such as inflammatory infections occur, Screening efficiency is critical; the simplicity is critical when it comes to chronic disease management such as blood glucose monitoring. In terms of IVD classification, POCT is a unique existence, which is not divided according to the sample type or the methodology, but is proposed according to the application scenario [1]. Therefore, POCT is a development direction for all in vitro diagnostic equipment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Jani, I.V. and T.F. Peter, How point-of-care testing could drive innovation in global health. The New England Journal of Medicine, 2013; 368(24): p. 2319-24.
Waggoner, J.J. and B.A. Pinsky, Zika Virus: Diagnostics for an Emerging Pandemic Threat. Journal of clinical microbiology, 2016; 54(4): p. 860-7.
Murray, P., Laboratory strategies: meeting the increasing demand for point-of-care diagnostics. MLO: medical laboratory observer, 2014; 46(10): p. 20, 22.
Laksanasopin, T., et al., A smartphone dongle for diagnosis of infectious diseases at the point of care. Science translational medicine, 2015; 7(273): p. 273re1.
Kimani, F.W., et al., Rethinking the Design of Low-Cost Point-of-Care Diagnostic Devices. Micromachines, 2017; 8(11).
Whitehead, A.S., et al., Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. The Journal of Biological Chemistry, 1992; 267(6): p. 3862-7.
Dabrowski, R., W. Wawron and K. Kostro, Changes in CRP, SAA and haptoglobin produced in response to ovariohysterectomy in healthy bitches and those with pyometra. Theriogenology, 2007; 67(2): p. 321-7.
Xu, H., et al., Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages. Frontiers in immunology, 2019; 10: p. 127.
You, J., et al., Role of the IL-33/ST2/p38 signaling pathway in the immune response of corneal epithelial cells to Aspergillus fumigatus infection. International journal of ophthalmology, 2019; 12(4): p. 549-556.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Shanghai Scientific and Technical Publishers
About this chapter
Cite this chapter
Li, F., Xu, J., Wang, D., Wang, D., Shang, Y. (2021). POCT Products Outlook. In: Song, H., Yao, J. (eds) In Vitro Diagnostic Industry in China. Springer, Singapore. https://doi.org/10.1007/978-981-16-2316-5_15
Download citation
DOI: https://doi.org/10.1007/978-981-16-2316-5_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-2315-8
Online ISBN: 978-981-16-2316-5
eBook Packages: MedicineMedicine (R0)